Contact
searchSearch
HMP Global

Atopic Dermatitis

Featured

nail
News
Nail Abnormalities Common in Severe Atopic Dermatitis, Study Finds
06/09/2026
Jessica Garlewicz
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly...
06/09/2026
The Dermatologist
baby
News
Emergency Department Management of Pediatric Atopic Dermatitis Requires Accurate Triage and Structured Discharge Planning
06/09/2026
Jessica Garlewicz
Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of children in the United States and remains a frequent reason for emergency department visits.
Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of children in the United States and remains a frequent reason for emergency department visits.
Atopic dermatitis, the most...
06/09/2026
The Dermatologist
aging
News
Age-Specific Immune Signatures Identified Across the Atopic Dermatitis Lifespan
06/09/2026
Jessica Garlewicz
Using Cellular Indexing of Transcriptomes and Epitopes by sequencing, investigators simultaneously assessed transcriptomic and surface proteomic profiles across approximately 280,000 immune cells.
Using Cellular Indexing of Transcriptomes and Epitopes by sequencing, investigators simultaneously assessed transcriptomic and surface proteomic profiles across approximately 280,000 immune cells.
Using Cellular Indexing of...
06/09/2026
The Dermatologist
AI
News
Machine Learning Identifies Potential Dual-Target Compounds for Atopic Dermatitis
05/05/2026
Jessica Garlewicz
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling...
05/05/2026
The Dermatologist
burden
News
Cutaneous Pain in Atopic Dermatitis Linked to Higher Psychological Burden
05/05/2026
Jessica Garlewicz
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic...
05/05/2026
The Dermatologist
News
POEM Scores Align With Clinical Severity and Treatment Intensity in Pediatric Atopic Dermatitis
05/05/2026
Jessica Garlewicz
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema...
05/05/2026
The Dermatologist
AD
News
Upadacitinib 30 mg Emerges as Most Effective Oral JAK Inhibitor for Moderate-to-Severe Atopic Dermatitis in Bayesian Meta-Analysis
03/31/2026
Riya Gandhi, MA
Comparative data across 9 randomized trials position upadacitinib at the top for skin clearance and itch reduction.
Comparative data across 9 randomized trials position upadacitinib at the top for skin clearance and itch reduction.
Comparative data across 9...
03/31/2026
The Dermatologist
AD
News
Upadacitinib 30 mg Ranks Most Effective Among Targeted Therapies for Atopic Dermatitis Without Topical Corticosteroids
03/31/2026
Riya Gandhi, MA
Updated network meta-analysis places upadacitinib at the top for multiple efficacy endpoints, including skin clearance and itch control.
Updated network meta-analysis places upadacitinib at the top for multiple efficacy endpoints, including skin clearance and itch control.
Updated network meta-analysis...
03/31/2026
The Dermatologist
News
Achieving Optimal Skin and Itch Targets Drives Superior Quality-of-Life Outcomes in Atopic Dermatitis
03/30/2026
Riya Gandhi, MA
Phase 3 data show patients reaching stringent treatment targets experience markedly greater improvements in sleep, pain, and mental health.
Phase 3 data show patients reaching stringent treatment targets experience markedly greater improvements in sleep, pain, and mental health.
Phase 3 data show patients...
03/30/2026
The Dermatologist
Atopic dermatitis
News
Upadacitinib Achieves Consistent Skin Clearance Across Body Regions in Real-World AD-VISE Study
03/30/2026
Riya Gandhi, MA
Real-world data show robust and consistent skin clearance with upadacitinib across body regions, regardless of prior biologic exposure.
Real-world data show robust and consistent skin clearance with upadacitinib across body regions, regardless of prior biologic exposure.
Real-world data show robust and...
03/30/2026
The Dermatologist
Atopic dermatitis
News
Upadacitinib Delivers Rapid, Sustained Improvements in Severe Atopic Dermatitis in Real-World Cohort
03/30/2026
Riya Gandhi, MA
A retrospective study shows high response rates and favorable safety in heavily pretreated patients, including those with difficult-to-treat anatomical involvement.
A retrospective study shows high response rates and favorable safety in heavily pretreated patients, including those with difficult-to-treat anatomical involvement.
A retrospective study shows high...
03/30/2026
The Dermatologist

Multimedia

Fall Clinical AD Roundtable
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following Fall Clinical
11/03/2022
Mona Shahriari, MD, FAAD
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs...
11/03/2022
The Dermatologist
Roundtable AAD
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAD
08/15/2022
Amy S. Paller, MD, MS
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
Drs Friedman, Lio, Shi and Kirkorian
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAAAI
07/15/2022
Adam Friedman, MD; Peter Lio, MD, FAAD; Vivian Shi, MD
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs...
07/15/2022
The Dermatologist
Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Shawn Kwatra, MD
Videos
ICYM RAD 2022: Dr Kwatra on Itch in Atopic Dermatitis
04/13/2022
Shawn Kwatra, MD
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual...
04/13/2022
The Dermatologist
Part 5 panel
Videos
Safety Monitoring in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Video 2 Drs Strasswimmer and Wong
Videos
Applying High-Risk Criteria in CSCC Practice
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion...
06/24/2026
The Dermatologist
Part 3 panel
Videos
Multidisciplinary Coordination in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel...
06/24/2026
The Dermatologist
Part 2 Patel and Barker
Videos
Integrating Adjuvant Therapy in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role...
06/24/2026
The Dermatologist
Drs Patel, Barker, Strasswimmer, and Wong
Videos
Recognizing High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the...
06/24/2026
The Dermatologist
Elliott Campbell
Videos
Innovations in Systemic Therapy for Advanced Nonmelanoma Skin Cancers
06/10/2026
Elliott Campbell, MD, FAAD; Riya Gandhi, MA
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment...
06/10/2026
The Dermatologist
green
Videos
Hormonal Therapy in Acne: DHT, Spironolactone, and Clascoterone
06/04/2026
Lawrence J. Green, MD, FAAD; Riya Gandhi, MA
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how...
06/04/2026
The Dermatologist
Minokadeh
Videos
Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques
06/04/2026
Ardalan Minokadeh, MD, PhD; Riya Gandhi, MA
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses...
06/04/2026
The Dermatologist
Ablon
Videos
Dermatology Retail and Skincare Recommendations: Evidence-Based Strategies for Practices
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how...
06/04/2026
The Dermatologist
draelos
Videos
Sunscreen Trends in Dermatology: SPF, Ingredient Safety, and Skin of Color
06/04/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Dr Zoe Diana Draelos discusses key sunscreen trends shaping dermatology practice, including SPF selection, water resistance, broad-spectrum protection, and evolving concerns around ingredient safety and AI-driven product rating apps.
Dr Zoe Diana Draelos discusses key sunscreen trends shaping dermatology practice, including SPF selection, water resistance, broad-spectrum protection, and evolving concerns around ingredient safety and AI-driven product rating apps.
Dr Zoe Diana Draelos discusses...
06/04/2026
The Dermatologist

From the Issue

Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Emma Guttman-Yassky, MD, PhD
Feature Story
Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod
10/10/2021
Peter Sonnenreich
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical...
10/10/2021
The Dermatologist
NEA Approved Features
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
NEA Approved Features
Quiz: Pain in Atopic Dermatitis
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Partner Approved
Get Eczema Wise During Eczema Awareness Month
10/16/2020
Lauren Mateja
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Feature Story
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
08/13/2020
Ana B. Rossi, MD, CMD; Brad Shumel, MD
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by...
08/13/2020
The Dermatologist
NEA Approved Features
Closing Gaps in Eczema Research
06/08/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
06/08/2026
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
HSF-Reviewed Content
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist
MASTERCLASSES IN DERMATOLOGY FORUM
Redefining Remission and Low Disease Activity in Dermatology
10/06/2025
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an...
10/06/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist
June 2026 issue

Current Issue

June 2026
Volume 34
Issue 4
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use